Overall operation was stable, with total revenue of RMB2,032 million (2023: RMB2,087 million). - Net property income stood at RMB1,445 million (2023: RMB1,475 million). - As at 31 December 2024, the ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where BioMarin Pharmaceutical Inc. (NASDAQ:BMRN ...

So, here we are, launching our fourth edition of Fierce Biotech's layoff tracker. As always, if you know of a layoff occurring at a biotech, please reach out to the Fierce Biotech editorial team ...

PDS Biotechnology is a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers. The Company has initiated a pivotal clinical trial to advance its ...

The Cambridge, Massachusetts-based biotech is closing “following careful consideration of potential paths forward and strategic factors,” HC CEO and cofounder Leslie Williams said in an ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to take a look at where Amgen Inc. (NASDAQ:AMGN) stands against other ...

Biotech stocks are in the eye of the storm as the world recovers from the global pandemic. Government institutions and professional traders are banking on biotech stocks to continually develop a ...

Incyte Corporation (NASDAQ:INCY) is a biopharmaceutical company at the forefront of biotechnology, focusing on drug discovery, clinical development, and commercialization of targeted therapies.

Vertiv’s P/E is high, but its forward P/E shows a discount. Find out why VRT stock could see strong returns with 100%+ EPS growth against the industry.

MEDLEY, Fla. (AP) — Unrivaled, the 3-on-3 women's basketball league founded by WNBA stars Breanna Stewart and Napheesa Collier, is eyeing a sustained future in women's sports after concluding its ...

Explore Purple Biotech stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for PPBT. Purple Biotech shares are trading lower by 28% during Tuesday's session.